AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20090313 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 20
Study 20090313 — intervention group
Group type: EXPERIMENTAL
Intervention: All fibers (12 g/day)
Number of subjects: 20
Study 17255841 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based ORS plus lactoferrin and lysozyme (Lf/Lz-R-ORS)
Number of subjects: 140
Study 17255841 — intervention group
Group type: COMPARATOR
Intervention: Low osmolarity WHO-ORS (G-ORS) and rice-based ORS (R-ORS) combined as control
Number of subjects: 140
Study 15377472 — intervention group
Group type: COMPARATOR
Intervention: CHOP chemotherapy
Number of subjects: 411
Study 15377472 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP + G-CSF
Number of subjects: 411
Study 11702619 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide plus 1% clindamycin
Number of subjects: 480
Study 11702619 — intervention group
Group type: COMPARATOR
Intervention: 5% benzoyl peroxide
Number of subjects: 480
Study 11702619 — intervention group
Group type: COMPARATOR
Intervention: 1% clindamycin
Number of subjects: 480
Study 11702619 — intervention group
Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 480
Study 9590570 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25-100 mg daily)
Number of subjects: 37
Study 9590570 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50-100 mg daily)
Number of subjects: 37
Study 9590570 — intervention group
Group type: COMPARATOR
Intervention: Captopril and Atenolol
Number of subjects: 37
Study 7931870 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (labeled low-fat entrees on menus and parent notification)
Number of subjects: 2445
Study 7931870 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 2445
Study 7931870 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents surveyed after intervention
Number of subjects: 2445
Study 3281774 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.2 mg)
Number of subjects: 40
Study 3281774 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (120 mg)
Number of subjects: 40
Study 3281774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg)
Number of subjects: 40
Study 3281774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31339789 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent influenza vaccine (QIV) information and education
Number of subjects: 4430
Study 31339789 — intervention group
Group type: EXPERIMENTAL
Intervention: Junior college degree
Number of subjects: 4430
Study 31339789 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher influenza knowledge level (medium level)
Number of subjects: 4430
Study 31339789 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher influenza knowledge level (high level)
Number of subjects: 4430
Study 31339789 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous influenza information
Number of subjects: 4430
Study 31339789 — intervention group
Group type: COMPARATOR
Intervention: No previous QIV-related information
Number of subjects: 4430
Study 31339789 — intervention group
Group type: COMPARATOR
Intervention: No perceived susceptibility of children to influenza
Number of subjects: 4430
Study 31339789 — intervention group
Group type: COMPARATOR
Intervention: Fear of side effects
Number of subjects: 4430
Study 31339789 — intervention group
Group type: COMPARATOR
Intervention: Concern that vaccines need to be carefully administered
Number of subjects: 4430
Study 31339789 — intervention group
Group type: COMPARATOR
Intervention: Mistrust of new vaccines
Number of subjects: 4430
Study 30213012 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose IFNα‐2b (9 million IU)
Number of subjects: 90
Study 30213012 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of high-dose IFNα‐2b and red light therapy
Number of subjects: 90
Study 30213012 — intervention group
Group type: COMPARATOR
Intervention: Low-dose recombinant IFNα‐2b (1 million IU)
Number of subjects: 90
Study 27761471 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity monitor
Number of subjects: 187
Study 27761471 — intervention group
Group type: COMPARATOR
Intervention: Pedometer
Number of subjects: 187
Study 24656288 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitaxentan 50 mg
Number of subjects: 246
Study 24656288 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitaxentan 100 mg
Number of subjects: 246
Study 24656288 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan 125 mg
Number of subjects: 246
Study 24656288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium oxide sandblasting (AO)
Number of subjects: 50
Study 22410401 — intervention group
Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine diamond bur (FDB)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium diamond bur (MDB)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse diamond bur (CDB)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic adhesive (Adper Single Bond 2, 3M ESPE)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic adhesive (Scotchbond Multi‐Purpose Plus, 3M ESPE)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface roughness (SR)
Number of subjects: 50
Study 22410401 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface area (SA)
Number of subjects: 50
Study 20405138 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 50
Study 20405138 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine
Number of subjects: 50
Study 20405138 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine + Arginine (combined)
Number of subjects: 50
Study 18212033 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy
Number of subjects: 43
Study 15723993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (10 minutes of ischemia and 10 minutes of reperfusion prior to Pringle maneuver)
Number of subjects: 75
Study 15723993 — intervention group
Group type: COMPARATOR
Intervention: Pringle maneuver
Number of subjects: 75
Study 15723993 — intervention group
Group type: COMPARATOR
Intervention: No Pringle maneuver
Number of subjects: 75
Study 14967189 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-patch therapy for 8 weeks
Number of subjects: 68
Study 14967189 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-patch therapy
Number of subjects: 68
Study 14967189 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study 11137103 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid variables including total cholesterol, LDL cholesterol, HDL cholesterol, VLDL cholesterol, triglycerides, and LDL/HDL ratio
Number of subjects: 0
Study 11137103 — intervention group
Group type: COMPARATOR
Intervention: Combined lipid variables
Number of subjects: 0
Study 9272748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide treatment
Number of subjects: 28
Study 8059505 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocelectomy
Number of subjects: 0
Study 3066967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryodipine (30 mg single dose)
Number of subjects: 23
Study 3066967 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (single dose)
Number of subjects: 23
Study 3066967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryodipine (150 mg/day for a short period)
Number of subjects: 23
Study 3066967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryodipine (150 mg/day)
Number of subjects: 23
Study 3066967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ryodipine (250 mg/day)
Number of subjects: 23
Study 31246277 — intervention group
Group type: EXPERIMENTAL
Intervention: API-AI regimen
Number of subjects: 106
Study 31209710 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided local insulin injection
Number of subjects: 60
Study 31209710 — intervention group
Group type: COMPARATOR
Intervention: Single injection of 40 mg methylprednisolone acetate
Number of subjects: 60
Study 31209710 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid injection followed by insulin injection twice after 2 and 4 weeks
Number of subjects: 60
Study 27468867 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary cell free DNA testing
Number of subjects: 150
Study 27468867 — intervention group
Group type: EXPERIMENTAL
Intervention: T790M+ group
Number of subjects: 150
Study 26233572 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (233mg zinc gluconate containing 30mg zinc)
Number of subjects: 58
Study 26233572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 23510646 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Teamplay parenting program)
Number of subjects: 75
Study 23510646 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 21615456 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI and AeroChamber Plus™
Number of subjects: 12
Study 21615456 — intervention group
Group type: COMPARATOR
Intervention: pMDI alone
Number of subjects: 12
Study 21615456 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI and charcoal ingestion
Number of subjects: 12
Study 19110788 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple stenting strategy (MV group)
Number of subjects: 413
Study 19110788 — intervention group
Group type: COMPARATOR
Intervention: Complex stenting strategy (MV+SB group)
Number of subjects: 413
Study 16869483 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta-beta training
Number of subjects: 38
Study 16869483 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP training
Number of subjects: 38
Study 12929098 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA) and adjunctive balloon angioplasty (PTCA)
Number of subjects: 56
Study 12929098 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (PTCA) alone
Number of subjects: 56
Study 12929098 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA)
Number of subjects: 56
Study 12929098 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure strategy after RA
Number of subjects: 56
Study 12929098 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (PTCA)
Number of subjects: 56
Study 11138997 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 54
Study 11138997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 9084600 — intervention group
Group type: EXPERIMENTAL
Intervention: New learning condition with feedback (correct/incorrect moves)
Number of subjects: 0
Study 9084600 — intervention group
Group type: COMPARATOR
Intervention: Free selection task (no feedback)
Number of subjects: 0
Study 9084600 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive movement of the same finger
Number of subjects: 0
Study 9084600 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline condition (pacing tones and auditory feedback, no movements)
Number of subjects: 0
Study 8471818 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day n‐3 fatty acids
Number of subjects: 9
Study 8471818 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 g/day n‐3 fatty acids
Number of subjects: 9
Study 8471818 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 fatty acids treatment
Number of subjects: 9
Study 3899152 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 0.5 mg i.v.
Number of subjects: 47
Study 3899152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 31604574 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of radiomics and clinical models
Number of subjects: 295
Study 31604574 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 295
Study 31604574 — intervention group
Group type: COMPARATOR
Intervention: Radiomics model
Number of subjects: 295
Study 27977518 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise (PRE)
Number of subjects: 48
Study 27977518 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Fitness Counts (mFC)
Number of subjects: 48
Study 27977518 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 48
Study 25909465 — intervention group
Group type: EXPERIMENTAL
Intervention: Elder Tree (information and communication technology) for 18 months
Number of subjects: 0
Study 25909465 — intervention group
Group type: COMPARATOR
Intervention: Usual sources of information and communication
Number of subjects: 0
Study 25909465 — intervention group
Group type: EXPERIMENTAL
Intervention: Elder Tree
Number of subjects: 0
Study 23608592 — intervention group
Group type: COMPARATOR
Intervention: PVI+LL
Number of subjects: 264
Study 23608592 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI+GP
Number of subjects: 264
Study 20674982 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 177
Study 20674982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 177
Study 19644031 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (ME) at 12% O2 for 30 min
Number of subjects: 15
Study 19644031 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (ME) at 15% O2 for 30 min
Number of subjects: 15
Study 19644031 — intervention group
Group type: EXPERIMENTAL
Intervention: Strenuous exercise (SE) at 21% O2
Number of subjects: 15
Study 19644031 — intervention group
Group type: COMPARATOR
Intervention: Moderate exercise (ME) at 21% O2
Number of subjects: 15
Study 19644031 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting at 12% O2 for 30 min
Number of subjects: 15
Study 19644031 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting at 15% O2 for 30 min
Number of subjects: 15
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 0
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced form of CBT
Number of subjects: 0
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative cognitive-affective therapy
Number of subjects: 0
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted and unassisted self-help
Number of subjects: 0
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment approaches
Number of subjects: 0
Study 17080448 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment modeling
Number of subjects: 0
Study 15631318 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole alone (O)
Number of subjects: 43
Study 15631318 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole and amoxicillin (OA)
Number of subjects: 43
Study 15631318 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole, amoxicillin and tinidazole (OAT)
Number of subjects: 43
Study 11414346 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) coping skills training
Number of subjects: 250
Study 11414346 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactional therapy
Number of subjects: 250
Study 11414346 — intervention group
Group type: COMPARATOR
Intervention: Random treatment assignment
Number of subjects: 250
Study 11414346 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective matching
Number of subjects: 250
Study 9715740 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (10 g day-1)
Number of subjects: 10
Study 9715740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (glucose polymers)
Number of subjects: 10
Study 7839282 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular magnesium sulphate regimen (loading dose of 14 g: 4 g i.v. and 10 g IM, followed by 5 g 4-hourly)
Number of subjects: 17
Study 7839282 — intervention group
Group type: COMPARATOR
Intervention: Intravenous magnesium sulphate regimen (loading dose of 6 g i.v., followed by maintenance infusion of 2 g/h)
Number of subjects: 17
Study 3402353 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil 25 mg intravenously
Number of subjects: 6
Study 3402353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30561313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole preventive therapy
Number of subjects: 2152
Study 30561313 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drugs
Number of subjects: 2152
Study 30561313 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased age
Number of subjects: 2152
Study 30561313 — intervention group
Group type: COMPARATOR
Intervention: Antibacterial drugs (general)
Number of subjects: 2152
Study 30561313 — intervention group
Group type: COMPARATOR
Intervention: Penicillins
Number of subjects: 2152
Study 30561313 — intervention group
Group type: COMPARATOR
Intervention: Sulfonamides
Number of subjects: 2152
Study 28097295 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic β-blocker use
Number of subjects: 8063
Study 28097295 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACEIs)
Number of subjects: 8063
Study 28097295 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers (ARBs)
Number of subjects: 8063
Study 28097295 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 8063
Study 28097295 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylureas
Number of subjects: 8063
Study 25730540 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine cream (SSD)
Number of subjects: 8
Study 25730540 — intervention group
Group type: COMPARATOR
Intervention: Water-soluble polyantimicrobial gel (BWG)
Number of subjects: 8
Study 23261228 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 150mg bid for 6 months
Number of subjects: 61
Study 23261228 — intervention group
Group type: COMPARATOR
Intervention: Placebo bid for 6 months
Number of subjects: 61
Study 20656508 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual weight-based dose of IV t-PA (administered dose divided by actual weight, capped at 100 kg)
Number of subjects: 311
Study 20656508 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual weight-based dose of IV t-PA
Number of subjects: 311
Study 19337705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-PRESS implantation under a scleral flap
Number of subjects: 78
Study 19337705 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 78
Study 17299064 — intervention group
Group type: EXPERIMENTAL
Intervention: Pio (7.5 mg/d) + Flu (62.5 mg/d) + Met (850 mg/d) + transdermal estroprogestagen
Number of subjects: 38
Study 17299064 — intervention group
Group type: COMPARATOR
Intervention: Flu (62.5 mg/d) + Met (850 mg/d) + transdermal estroprogestagen
Number of subjects: 38
Study 15159232 — intervention group
Group type: COMPARATOR
Intervention: WB (12 g fiber/d)
Number of subjects: 20
Study 15159232 — intervention group
Group type: COMPARATOR
Intervention: WBRS (12 g WB fiber/d plus 22 g RS/d)
Number of subjects: 20
Study 12743147 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive (SE) therapy group
Number of subjects: 235
Study 12743147 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no SE)
Number of subjects: 235
Study 12743147 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SE therapy and control)
Number of subjects: 235
Study 10426704 — intervention group
Group type: EXPERIMENTAL
Intervention: High-vegetable diet (490 g/d)
Number of subjects: 54
Study 10426704 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-vegetable diet supplemented with beta-carotene (6 mg/d) and lutein (9 mg/d)
Number of subjects: 54
Study 10426704 — intervention group
Group type: COMPARATOR
Intervention: Low-vegetable diet (130 g/d)
Number of subjects: 54
Study 7750429 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium citrate (120 mmol daily for 8 weeks)
Number of subjects: 25
Study 7750429 — intervention group
Group type: COMPARATOR
Intervention: Potassium chloride (120 mmol daily for 8 weeks)
Number of subjects: 25
Study 7750429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2180461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily (n = 41)
Number of subjects: 189
Study 2180461 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 800 mg nocte (n = 38)
Number of subjects: 189
Study 2180461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 189
Study 2180461 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 800 mg nocte
Number of subjects: 189
Study 535840 — intervention group
Group type: EXPERIMENTAL
Intervention: Frubiase Calcium forte (1 x 6 fluid ampoules)
Number of subjects: 20
Study 535840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31883223 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance and aerobic exercise training (CET) for 3 months, consisting of 30-min aerobic and 30-min resistance exercises three times a week for 12 weeks.
Number of subjects: 48
Study 31883223 — intervention group
Group type: COMPARATOR
Intervention: Sedentary group (SG)
Number of subjects: 48
Study 30509771 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg orally per day)
Number of subjects: 3966
Study 30509771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3966
Study 30292279 — intervention group
Group type: EXPERIMENTAL
Intervention: CT texture analysis (specifically stdDeviation)
Number of subjects: 69
Study 30292279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross validation SVM classifiers
Number of subjects: 69
Study 30292279 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-ROIs
Number of subjects: 69
Study 30292279 — intervention group
Group type: COMPARATOR
Intervention: Subjective heterogeneity scores
Number of subjects: 69
Study 26808474 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg bid)
Number of subjects: 371
Study 24471979 — intervention group
Group type: EXPERIMENTAL
Intervention: MAL-PDT treatment
Number of subjects: 27